Evidence map›Paper›PMID 42305977›Full record

ReviewFrontiers in medicine2026

Beta

Neil Skolnik, Jessica Stieritz, Julie Akers, Timothy Hudd, Wendy L Wright, Ileen Gilbert, Nazrin Yusufova, Bill Cook, Emily Robb, Henry Naddaf

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Neil SkolnikSidney Kimmel Medical College, Jenkintown, PA, United States.
Jessica StieritzSidney Kimmel Medical College, Jenkintown, PA, United States.
Julie AkersCollege of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, United States.
Timothy HuddMassachusetts College of Pharmacy and Health Sciences, Boston, MA, United States.
Wendy L WrightWright & Associates Family Healthcare, Amherst, NH, United States.
Ileen GilbertBioPharmaceuticals, United States Medical, AstraZeneca, Wilmington, DE, United States.
Nazrin YusufovaBioPharmaceuticals, United States Medical, AstraZeneca, Wilmington, DE, United States.
Bill CookBioPharmaceuticals, Global Medical Affairs, AstraZeneca, Gaithersburg, MD, United States.
Emily RobbErnest Mario School of Pharmacy, Rutgers University, Newark, NJ, United States.
Henry NaddafThe Toledo Clinic, Family Medicine, Toledo, OH, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Global Initiative for Asthma (GINA) report and national and international guidelines have shifted away from short-acting beta

Indexed as

asthmaexacerbationinhaled corticosteroidsrescue therapyshort-acting beta2-agonists

Identifiers

PMID42305977
PMCPMC13266595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.